DE3783039T2 - Membran lipid zusammensetzung und verfahren zur herstellung. - Google Patents

Membran lipid zusammensetzung und verfahren zur herstellung.

Info

Publication number
DE3783039T2
DE3783039T2 DE8787903720T DE3783039T DE3783039T2 DE 3783039 T2 DE3783039 T2 DE 3783039T2 DE 8787903720 T DE8787903720 T DE 8787903720T DE 3783039 T DE3783039 T DE 3783039T DE 3783039 T2 DE3783039 T2 DE 3783039T2
Authority
DE
Germany
Prior art keywords
lipid
active compound
membrane lipid
biologically active
propellant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787903720T
Other languages
English (en)
Other versions
DE3783039D1 (de
Inventor
Steven Leigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INYX INC., NEW YORK, N.Y., US
Original Assignee
PHARES PHARMA HOLLAND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARES PHARMA HOLLAND filed Critical PHARES PHARMA HOLLAND
Publication of DE3783039D1 publication Critical patent/DE3783039D1/de
Application granted granted Critical
Publication of DE3783039T2 publication Critical patent/DE3783039T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Disintegrating Or Milling (AREA)
DE8787903720T 1986-06-06 1987-06-05 Membran lipid zusammensetzung und verfahren zur herstellung. Expired - Lifetime DE3783039T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868613811A GB8613811D0 (en) 1986-06-06 1986-06-06 Composition & method
PCT/GB1987/000391 WO1987007502A1 (en) 1986-06-06 1987-06-05 Composition and method

Publications (2)

Publication Number Publication Date
DE3783039D1 DE3783039D1 (de) 1993-01-21
DE3783039T2 true DE3783039T2 (de) 1993-06-24

Family

ID=10599066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787903720T Expired - Lifetime DE3783039T2 (de) 1986-06-06 1987-06-05 Membran lipid zusammensetzung und verfahren zur herstellung.

Country Status (6)

Country Link
EP (1) EP0309464B1 (de)
JP (1) JP2779165B2 (de)
AT (1) ATE83145T1 (de)
DE (1) DE3783039T2 (de)
GB (1) GB8613811D0 (de)
WO (1) WO1987007502A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
IT1243734B (it) * 1990-09-28 1994-06-21 Ruiu Rosa Sternberg Composizione per uso terapeutico e/o cosmetico per il trattamento di disturbi circolatori e per trattamenti di medicina estetica
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
FR2681781A1 (fr) 1991-09-30 1993-04-02 Oreal Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5554382A (en) * 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
US5635206A (en) * 1994-01-20 1997-06-03 Hoffmann-La Roche Inc. Process for liposomes or proliposomes
EP0812195B1 (de) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Arzneizubereitungen für piperidinalkanolderivate
DE19623950A1 (de) * 1996-06-15 1997-12-18 Boehringer Ingelheim Kg Pharmazeutische Zubereitung in Form von Liposomen
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IL146132A0 (en) 1999-05-27 2002-07-25 Euro Celtique Sa Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AU2001258117A1 (en) 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
CN101017164B (zh) * 2006-07-21 2011-08-31 上海中医药大学 脂质体药物包封率测定方法
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
US10722466B2 (en) 2016-10-28 2020-07-28 Les Laboratoires Servier Liposomal formulation for use in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.

Also Published As

Publication number Publication date
DE3783039D1 (de) 1993-01-21
GB8613811D0 (en) 1986-07-09
WO1987007502A1 (en) 1987-12-17
EP0309464B1 (de) 1992-12-09
JPH01502979A (ja) 1989-10-12
EP0309464A1 (de) 1989-04-05
JP2779165B2 (ja) 1998-07-23
ATE83145T1 (de) 1992-12-15

Similar Documents

Publication Publication Date Title
DE3783039D1 (de) Membran lipid zusammensetzung und verfahren zur herstellung.
PT84133B (pt) Processo de preparacao de uma formulacao farmaceutica solida de libertacao controlada a base de goma de xantano
MX9206305A (es) Bifenilpiridonas substitutas, procedimiento para su obtencion y medicamento que los contiene.
KR850007559A (ko) 조절 펩타이드의 삽입식 제형
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
KR890007739A (ko) 안정화된 의약물질, 이의 제조방법, 및 안정한 의약제제
CA2009890A1 (en) Valproic acid
ATE271381T1 (de) Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler
KR880000089A (ko) 서방형 약제 조성물
DE3872382D1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
DE59206699D1 (de) Redispergierbares Dispersionspulver aus N-Vinylpyrrolidon-Vinylacetat-Copolymerisat, dessen Herstellung und Verwendung
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ATE340639T1 (de) Verfahren zur herstellung von teilchen
KR900013964A (ko) 활성형 비타민 d₃류 제제용 조성물 및 이를 함유하는 안정한 활성형 비타민 d₃류 제제의 제조방법
ATE226428T1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
DE3783923T2 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
DE102014226098A1 (de) Mehrkomponentenklebstoff zur Herstellung eines Adhäsivhydrogels
DE69119488D1 (de) Disulfat von WS-7622A, Verfahren zur Herstellung und Benutzung
EP0362731A3 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten
MX9301057A (es) Nuevos esteres de oxima azoica, a procedimientos para su preparacion, a su uso como fungicidas y a composiciones que los comprenden.
SU585194A1 (ru) Полимерна композици
JPS57142906A (en) Insecticide
WO2014128272A1 (de) Mehrkomponentenklebstoff zur herstellung eines adhäsivhydrogels
AU633600B2 (en) Compositions

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: PHARES PHARMACEUTICAL HOLLAND B.V., AMSTERDAM, NL

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INYX INC., NEW YORK, N.Y., US